| __timestamp | Eli Lilly and Company | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 55962693 |
| Thursday, January 1, 2015 | 4796400000 | 78655788 |
| Friday, January 1, 2016 | 5243900000 | 95723069 |
| Sunday, January 1, 2017 | 5281800000 | 116808575 |
| Monday, January 1, 2018 | 5051200000 | 106397017 |
| Tuesday, January 1, 2019 | 5595000000 | 108431600 |
| Wednesday, January 1, 2020 | 6085700000 | 141426832 |
| Friday, January 1, 2021 | 7025900000 | 225200000 |
| Saturday, January 1, 2022 | 7190800000 | 297812160 |
| Sunday, January 1, 2023 | 9313400000 | 283614139 |
| Monday, January 1, 2024 | 14271000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Eli Lilly and Company has consistently outpaced MorphoSys AG in R&D investment. From 2014 to 2023, Eli Lilly's R&D expenses surged by nearly 97%, reaching a peak in 2023. In contrast, MorphoSys AG's R&D spending grew by approximately 406% over the same period, albeit from a much smaller base.
Eli Lilly's robust financial commitment underscores its strategic focus on pioneering new treatments, while MorphoSys AG's rapid growth in R&D spending highlights its aggressive push to expand its research capabilities. This comparison not only reflects the differing scales and strategies of these two companies but also offers a glimpse into the competitive dynamics of the pharmaceutical industry.
Eli Lilly and Company or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
R&D Spending Showdown: Eli Lilly and Company vs Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
Eli Lilly and Company vs Veracyte, Inc.: Strategic Focus on R&D Spending
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and MorphoSys AG